WntResearch restarts the NeoFox study in Hungary
The Hungarian health authorities now considers the COVID-19 pandemic under control, and Hungarian hospitals are thus able to resume normal operation. Following this notification, WntResearch has decided to start the NeoFox study in Hungary.After consulting Cato/SMS and Optimapharm, WntResearch has decided to restart NeoFox in Hungary. The Spanish part of the NeoFox study is considered to resume in September, due to the severe strain put on the Spanish healthcare system during the COVID-19 peak and with consideration to the low patient recruitment rate last August. An initial assessment